Clinical Trials Browser

Phase 2/3 × Hematologic Neoplasms × Darbepoetin alfa × Clear all

NCT00557817 2010-01-11

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Phase 2/3 Completed

Other hematologic neoplasm

Hematologic Neoplasms